Zobrazeno 1 - 10 of 176 pro vyhledávání: '"Kjell Magne, Tveit"'
1
Clinicopathological factors associated with tumour‐specific mutation detection in plasma of patients with RAS ‐mutated or BRAF ‐mutated metastatic colorectal cancer
Autor: Olav Dajani, Elin H. Kure, Per Pfeiffer, Bengt Glimelius, K. L.G. Spindler, Halfdan Sorbye, Ole Christian Lingjærde, Niels Pallisgaard, Tormod Kyrre Guren, Julian Hamfjord, Kjell Magne Tveit
Publikováno v: International Journal of Cancer. 149:1385-1397
Detection of tumour-specific circulating cell-free DNA in plasma (ctDNA) fails in a significant number of cases depending on the clinical context. The primary aim was to investigate clinicopathological factors associated with detection of ctDNA in pa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::542b285a746a26da02c56a6243657e3a
https://doi.org/10.1002/ijc.33672
Zobrazit plný text záznamu
2
Health-Related Quality of Life in Colorectal Cancer Patients Treated With Liver Transplantation Compared to Chemotherapy
Autor: Tor Magnus Smedman, Tormod Kyrre Guren, Kjell Magne Tveit, Maria Thomsen, Marit Helen Andersen, Pål-Dag Line, Svein Dueland
Publikováno v: Transplant International. 35
Liver transplantation (LT) for patients with non-resectable colorectal liver metastases (CRLM) offers improved survival and has gained increased interest internationally the last years. The aim of this study was to describe the health-related quality
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e69662fefd9a78ea627d2cde81a72755
https://doi.org/10.3389/ti.2022.10404
Zobrazit plný text záznamu
3
Survival Trends of Right- and Left-Sided Colon Cancer across Four Decades : A Norwegian Population-Based Study
Autor: Tor Åge Myklebust, Tormod Kyrre Guren, Elin H. Kure, Inger Kristin Larsen, Bengt Glimelius, Kjell Magne Tveit, Julian Hamfjord, Marianne Grønlie Guren
Publikováno v: Cancer Epidemiology, Biomarkers and Prevention
Background: Patients with right-sided colon cancer (RCC) and left-sided colon cancer (LCC) differ clinically and molecularly. The main objective was to investigate stage-stratified survival and recurrence of RCC and LCC across four 10-year periods. M
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fbffa9959ad02387b24f0f6c9ba0e65
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-469211
Zobrazit plný text záznamu
5
Akademický článek
Plasma YKL-40 in patients with metastatic colorectal cancer treated with first line oxaliplatin-based regimen with or without cetuximab: RESULTS from the NORDIC VII Study.
Autor: Line S Tarpgaard, Tormod K Guren, Bengt Glimelius, Ib J Christensen, Per Pfeiffer, Elin H Kure, Halfdan Sorbye, Tone Ikdahl, Mette Yilmaz, Julia S Johansen, Kjell Magne Tveit
Publikováno v: PLoS ONE, Vol 9, Iss 2, p e87746 (2014)
We aim to test the hypothesis that high plasma YKL-40 is associated with short progression-free survival (PFS) and overall survival (OS) in patients with metastatic colorectal cancer (mCRC) treated with first-line oxaliplatin and 5-flourouracil with
Externí odkaz: https://doaj.org/article/5220fea8fbdf4802a9079ec55874bed7
Zobrazit plný text záznamu
6
Clinicopathological factors associated with tumour-specific mutation detection in plasma of patients with RAS-mutated or BRAF-mutated metastatic colorectal cancer
Autor: Julian, Hamfjord, Tormod Kyrre, Guren, Bengt, Glimelius, Halfdan, Sorbye, Per, Pfeiffer, Olav, Dajani, Ole Christian, Lingjaerde, Kjell Magne, Tveit, Niels, Pallisgaard, Karen-Lise Garm, Spindler, Elin H, Kure
Publikováno v: International journal of cancerREFERENCES. 149(6)
Detection of tumour-specific circulating cell-free DNA in plasma (ctDNA) fails in a significant number of cases depending on the clinical context. The primary aim was to investigate clinicopathological factors associated with detection of ctDNA in pa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3e1dd90ab061b9525b2e3b0858df5912
https://pubmed.ncbi.nlm.nih.gov/33961700
Zobrazit plný text záznamu
7
Equitable access to cancer patient pathways in Norway – a national registry-based study
Autor: Lise Balteskard, Ivar Heuch, Kjell Magne Tveit, Bjarne K. Jacobsen, Frank Olsen
Publikováno v: BMC Health Services Research
BMC Health Services Research, Vol 21, Iss 1, Pp 1-13 (2021)
Background In 2015, cancer patient pathways (CPP) were implemented in Norway to reduce unnecessary non-medical delay in the diagnostic process and start of treatment. The main aim of this study was to investigate the equality in access to CPPs for pa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::920efb87259b3ef13afca2d9b5008957
https://hdl.handle.net/11250/2936423
Zobrazit plný text záznamu
8
Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer
Autor: Christian Kersten, Julia S. Johansen, Thoralf Christoffersen, Tormod Kyrre Guren, Kjell Magne Tveit, Tone Ikdahl, Maria Thomsen, Elin H. Kure, Eva Skovlund, Halfdan Sorbye, Per Pfeiffer, Bengt Glimelius
Publikováno v: Oncotarget
Thomsen, M, Kersten, C, Sorbye, H, Skovlund, E, Glimelius, B, Pfeiffer, P, Johansen, J S, Kure, E H, Ikdahl, T, Tveit, K M, Christoffersen, T & Guren, T K 2016, ' Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer ', Oncotarget, vol. 7, no. 46, pp. 75013-75022 . https://doi.org/10.18632/oncotarget.12601
Thomsen, M, Kersten, C, Sorbye, H, Skovlund, E, Glimelius, B, Pfeiffer, P, Johansen, J S, Kure, E H, Ikdahl, T, Tveit, K M, Christoffersen, T & Guren, T K 2016, ' Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer ', OncoTarget, vol. 7, no. 46, pp. 75013-75022 . https://doi.org/10.18632/oncotarget.12601
// Maria Thomsen 1, 2 , Christian Kersten 3 , Halfdan Sorbye 4 , Eva Skovlund 5 , Bengt Glimelius 6 , Per Pfeiffer 7 , Julia S. Johansen 8 , Elin H. Kure 9 , Tone Ikdahl 10 , Kjell Magne Tveit 1, 2, 11 , Thoralf Christoffersen 12 , Tormod Kyrre Guren
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13660df0705d1fc166d38b27ae047df3
http://europepmc.org/articles/PMC5342719
Zobrazit plný text záznamu
9
Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study
Autor: Maria Thomsen, Per Pfeiffer, Fridbjorn Sigurdsson, Inger Marie Bowitz Lothe, Bengt Glimelius, Pia Österlund, Kjell Magne Tveit, Eva Skovlund, Elin H. Kure, Halfdan Sorbye, Tormod Kyrre Guren, Thoralf Christoffersen, Astrid M. Dalsgaard
Publikováno v: British Journal of Cancer
Guren, T K, Thomsen, M M, Kure, E H, Sorbye, H, Glimelius, B, Pfeiffer, P, Österlund, P, Sigurdsson, F, Lothe, I M B, Dalsgaard, A M, Skovlund, E, Christoffersen, T & Tveit, K M 2017, ' Cetuximab in treatment of metastatic colorectal cancer : final survival analyses and extended RAS data from the NORDIC-VII study ', British Journal of Cancer, vol. 116, no. 10, pp. 1271-1278 . https://doi.org/10.1038/bjc.2017.93
BACKGROUND: The NORDIC-VII study is a randomised phase III trial of cetuximab plus continuous or intermittent fluorouracil, folinic acid, and oxaliplatin (Nordic FLOX) vs FLOX alone in first-line treatment of metastatic colorectal cancer. The present
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee4167376ac87d2e8d8719d29d555e86
https://doi.org/10.1038/bjc.2017.93
Zobrazit plný text záznamu
10
Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy
Autor: Elin H. Kure, Halfdan Sorbye, Kjell Magne Tveit, Niels Pallisgaard, Olav Dajani, K. L.G. Spindler, Ole Christian Lingjærde, Julian Hamfjord, Tormod Kyrre Guren, Per Pfeiffer, Bengt Glimelius, Julia S. Johansen
Publikováno v: Hamfjord, J, Guren, T K, Dajani, O, Johansen, J S, Glimelius, B, Sorbye, H, Pfeiffer, P, Lingjærde, O C, Tveit, K M, Kure, E H, Pallisgaard, N & Spindler, K-L G 2019, ' Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy ', Annals of Oncology, vol. 30, no. 7, pp. 1088-1095 . https://doi.org/10.1093/annonc/mdz139
Annals of Oncology
Hamfjord, J, Guren, T K, Dajani, O, Johansen, J S, Glimelius, B, Sorbye, H, Pfeiffer, P, Lingjærde, O C, Tveit, K M, Kure, E H, Pallisgaard, N & Spindler, K L G 2019, ' Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy ', Annals of Oncology, vol. 30, no. 7, mdz139, pp. 1088-1095 . https://doi.org/10.1093/annonc/mdz139
BACKGROUND: Metastatic colorectal cancer (mCRC) is a heterogeneous disease where prognosis is dependent both on tumor biology and host factors. Total circulating cell-free DNA (cfDNA) has shown to harbor prognostic information in mCRC, although less
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::360d1d22c619f922ee55d965bc432fc4
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-394653
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje